Found: 12
Select item for more details and to access through your institution.
Cutaneous Events Associated with Immunotherapy of Melanoma: A Review.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 14, p. 3047, doi. 10.3390/jcm10143047
- By:
- Publication type:
- Article
Drug survival, effectiveness, and safety of brodalumab for moderate‐to‐severe psoriasis up to 3 years.
- Published in:
- International Journal of Dermatology, 2024, v. 63, n. 7, p. 922, doi. 10.1111/ijd.17038
- By:
- Publication type:
- Article
Certolizumab pegol and its role in pregnancy‐age hidradenitis suppurativa.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 5, p. e182, doi. 10.1111/ijd.15742
- By:
- Publication type:
- Article
Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.5278
- By:
- Publication type:
- Article
Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.2926
- By:
- Publication type:
- Article
Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report.
- Published in:
- Acta Dermato-Venereologica, 2021, v. 101, n. 5, p. 1, doi. 10.2340/00015555-3798
- By:
- Publication type:
- Article
Effectiveness of Brodalumab on Scalp, Palmoplantar, and Genital Psoriasis: A Descriptive Pilot Study.
- Published in:
- Dermatologic Therapy, 2023, p. 1, doi. 10.1155/2023/1793535
- By:
- Publication type:
- Article
Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15866
- By:
- Publication type:
- Article
Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost‐effectiveness?
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15803
- By:
- Publication type:
- Article
Persistent eruptive lentiginosis in a psoriatic patient after 4‐year effective treatment with ustekinumab.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 6, p. 1, doi. 10.1111/dth.15468
- By:
- Publication type:
- Article
Guselkumab in the treatment of severe hidradenitis suppurativa, a promising role?
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 3, p. 1, doi. 10.1111/dth.14930
- By:
- Publication type:
- Article
Low‐dose oral minoxidil in female patients with lichen planopilaris: Real‐life experience.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 1, p. e98, doi. 10.1111/jdv.18489
- By:
- Publication type:
- Article